BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 34410397)

  • 1. Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
    Wang W; Peng Y; Feng X; Zhao Y; Seeruttun SR; Zhang J; Cheng Z; Li Y; Liu Z; Zhou Z
    JAMA Netw Open; 2021 Aug; 4(8):e2121143. PubMed ID: 34410397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer.
    Sun KY; Hu HT; Chen SL; Ye JN; Li GH; Chen LD; Peng JJ; Feng ST; Yuan YJ; Hou X; Wu H; Li X; Wu TF; Wang W; Xu JB
    BMC Cancer; 2020 May; 20(1):468. PubMed ID: 32450841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
    Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
    EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-based radiomics analysis in the prediction of response to neoadjuvant chemotherapy in locally advanced gastric cancer: A dual-center study.
    Song R; Cui Y; Ren J; Zhang J; Yang Z; Li D; Li Z; Yang X
    Radiother Oncol; 2022 Jun; 171():155-163. PubMed ID: 35490846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.
    Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Chiu KWH; Fu J; Vardhanabhuti V
    JAMA Netw Open; 2020 Sep; 3(9):e2015927. PubMed ID: 32910196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of response to neoadjuvant chemotherapy in advanced gastric cancer: A radiomics nomogram analysis based on CT images and clinicopathological features.
    Tan X; Yang X; Hu S; Ge Y; Wu Q; Wang J; Sun Z
    J Xray Sci Technol; 2023; 31(1):49-61. PubMed ID: 36314190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of computed tomography features in assessing response to neoadjuvant chemotherapy in locally advanced gastric cancer.
    Wei C; He Y; Luo M; Chen G; Nie R; Chen X; Zhou Z; Chen Y
    BMC Cancer; 2023 Nov; 23(1):1157. PubMed ID: 38012547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Learning Radiomics Nomogram Based on Enhanced CT to Predict the Response of Metastatic Lymph Nodes to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer.
    Zhong H; Wang T; Hou M; Liu X; Tian Y; Cao S; Li Z; Han Z; Liu G; Sun Y; Meng C; Li Y; Jiang Y; Ji Q; Hao D; Liu Z; Zhou Y
    Ann Surg Oncol; 2024 Jan; 31(1):421-432. PubMed ID: 37925653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced gastric cancer: CT radiomics prediction and early detection of downstaging with neoadjuvant chemotherapy.
    Xu Q; Sun Z; Li X; Ye C; Zhou C; Zhang L; Lu G
    Eur Radiol; 2021 Nov; 31(11):8765-8774. PubMed ID: 33909133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of MRI and CT-Based Radiomics and Their Combination for Early Identification of Pathological Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer.
    Li J; Zhang HL; Yin HK; Zhang HK; Wang Y; Xu SN; Ma F; Gao JB; Li HL; Qu JR
    J Magn Reson Imaging; 2023 Sep; 58(3):907-923. PubMed ID: 36527425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of dual-energy CT derived radiomics signatures in predicting outcomes in patients with advanced gastric cancer after neoadjuvant chemotherapy.
    Chen Y; Yuan F; Wang L; Li E; Xu Z; Wels M; Yao W; Zhang H
    Eur J Surg Oncol; 2022 Feb; 48(2):339-347. PubMed ID: 34304951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning radio-clinical signatures for predicting neoadjuvant chemotherapy response and prognosis from pretreatment CT images of locally advanced gastric cancer patients.
    Hu C; Chen W; Li F; Zhang Y; Yu P; Yang L; Huang L; Sun J; Chen S; Shi C; Sun Y; Ye Z; Yuan L; Chen J; Wei Q; Xu J; Xu H; Tong Y; Bao Z; Huang C; Li Y; Du Y; Xu Z; Cheng X
    Int J Surg; 2023 Jul; 109(7):1980-1992. PubMed ID: 37132183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
    Jiang Y; Liang X; Han Z; Wang W; Xi S; Li T; Chen C; Yuan Q; Li N; Yu J; Xie Y; Xu Y; Zhou Z; Poultsides GA; Li G; Li R
    Lancet Digit Health; 2021 Jun; 3(6):e371-e382. PubMed ID: 34045003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment Contrast-Enhanced Computed Tomography Radiomics for Prediction of Pathological Regression Following Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Preliminary Multicenter Study.
    Xie K; Cui Y; Zhang D; He W; He Y; Gao D; Zhang Z; Dong X; Yang G; Dai Y; Li Z
    Front Oncol; 2021; 11():770758. PubMed ID: 35070974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer.
    Jiang Y; Chen C; Xie J; Wang W; Zha X; Lv W; Chen H; Hu Y; Li T; Yu J; Zhou Z; Xu Y; Li G
    EBioMedicine; 2018 Oct; 36():171-182. PubMed ID: 30224313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of computed tomography radiomics features in patients with gastric cancer following curative resection.
    Li W; Zhang L; Tian C; Song H; Fang M; Hu C; Zang Y; Cao Y; Dai S; Wang F; Dong D; Wang R; Tian J
    Eur Radiol; 2019 Jun; 29(6):3079-3089. PubMed ID: 30519931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma.
    Lin P; Yang PF; Chen S; Shao YY; Xu L; Wu Y; Teng W; Zhou XZ; Li BH; Luo C; Xu LM; Huang M; Niu TY; Ye ZM
    Cancer Imaging; 2020 Jan; 20(1):7. PubMed ID: 31937372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
    Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
    JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter study.
    Chen H; Zhang X; Wang X; Quan X; Deng Y; Lu M; Wei Q; Ye Q; Zhou Q; Xiang Z; Liang C; Yang W; Zhao Y
    Eur Radiol; 2021 Oct; 31(10):7913-7924. PubMed ID: 33825032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.